Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD. (Q43148854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

2

Tai Hing Lam

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

Chao Qiang Jiang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

7

Bernard M Y Cheung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

4

Jie Ming Lin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

5

Xiao Jun Yue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Bin Liu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ya Li Jin

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

25 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1969-1974

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186139%20AND%20SRC:MED&resulttype=core&format=json

Inflammation, atherosclerosis, and coronary artery disease

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Interleukin-6 and diabetes: the good, the bad, or the indifferent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Interleukin 6 and haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

No association of interleukin-6 gene polymorphism (-174 G/C) with myocardial infarction or traditional cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Interleukin-6-572C>G polymorphism-association with inflammatory variables in Korean men with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Joint analysis of individual participants' data from 17 studies on the association of the IL6 variant -174G>C with circulating glucose levels, interleukin-6 levels, and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

The -174 IL-6 GG genotype is associated with a reduced risk of type 2 diabetes mellitus in a family sample from the National Heart, Lung and Blood Institute's Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

An overview of the Guangzhou biobank cohort study-cardiovascular disease subcohort (GBCS-CVD): a platform for multidisciplinary collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Molecular screening and association analyses of the interleukin 6 receptor gene variants with type 2 diabetes, diabetic nephropathy, and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Some comments on frequently used multiple endpoint adjustment methods in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

An immune origin of type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Interleukin-6 and the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Effects of endotoxin and cytokines on lipid metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31

Autocrine up-regulation of glucocorticoid receptors by interleukin-6 in human osteoblast-like cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2010.31